Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Ron Can you confirm: I checked the sec filings those were filed on feb 10: are these 5% ownership for Blackrock and Vanguard was as of Dec 31.
How to confirm that info.
What i thought was institutions must file with SEC within 7days of the transaction is that true?
QCOR one drug wonder : CNBC - Don Bailey
http://video.cnbc.com/gallery/?video=3000057860
QCOR one drug wonder : CNBC - Don Bailey
http://video.cnbc.com/gallery/?video=3000057860
QCOR: BLACKROCK and VANGAURD bought shares represents more than 5%...
BlackRock Bought:4,775,604 shares represents : 7.61% of total holdings.
Vangaurd bought addtional: 76,335 shares, now there total holdings are 3,337,563 shares
http://www.nasdaq.com/symbol/qcor/sec-filings
Two possiblities next two weeks:
1. relatively small sell off (bad news already factored in)
2. Extreme short squeeze driving stock up.
BlackRock Bought:4,775,604 shares represents : 7.61% of total holdings.
Vangaurd bought addtional: 76,335 shares, now there total holdings are 3,337,563 shares
http://www.nasdaq.com/symbol/qcor/sec-filings
Two possiblities next two weeks:
1. relatively small sell off (bad news already factored in)
2. Extreme short squeeze driving stock up.
Options expiration week...
what do you expect after 18 green trading days..
Will get in Low $7.... by friday.
320k volume....
Short interest still 2.1 mil
As of dec 31st they have covered only 5k shares.......
$31.52......thanks a lot.
Thank you Dav, Bought IPCM.
Is it good to hold....
Thank you Dav, Bought IPCM.
Is it good to hold....
IS TSPT a good short, $8 plus....
TSPT $8 plus any news or shorts setup?
Here are few FDA approved drugs had enough cash to market their drug:
dndn, itmn, somx, depo, xnpt, ais, igxt, fcsc, pcrx, pozn, hgsi, optr, SVNt, avnr.
Take a look at the current price.
Shorted TSPT 4.3k shares @ $8.03
This is my 5th time shorting this...........
AMRN 52 week low.........
AMRN 2011 low amazing
AMRN $6.25..... Absurdly low bounce alert...
AMRN $6.30 bounce alert
AMRN .... $6.30 Bounce alert...
AMRN $6.34.....bounce alert
AMRN.... $6.34
AMRN below $6.40.... bounce alert
AMRN absurdly low ..... Bounce alert.
AMRN absurdly low bounce alert....
AMRN below $6.5..........
AMRN below $6.5 ..............
News Breaks
December 12, 2011
13:10 EDT QCOR theflyonthewall.com: Questcor sinks after reporting Acthar prescriptions
Questcor (QCOR) is retreating after the company announced that there were 615-625 paid prescriptions of its main Acthar Gel for the treatment of multiple sclerosis from October 1 to November 30, down from 886 during its third quarter ended September 25. Prescriptions for Acthar for the treatment of nephrotic syndrome came in between 83-87 from October 1 to November 30, up from 60 in Q3. Finally, there were 88-92 new Acthar prescriptions for the treatment of infantile spasms, down from 112 in Q3. In a note to investors, Oppenheimer said Questcor's update is "largely positive." Questcor's Q4 revenue should exceed Oppenheimer's estimate of $66.6M by as much a $6M-$90m, added the firm. While Oppenheimer understands why people are concerned about the decline in MS prescriptions, it notes that prescriptions typically accelerate towards the end of each quarter, and it recommends buying the stock on today’s weakness. In mid-afternoon trading, Questcor fell $2.45, or 5.37%, to $43.14. :theflyonthewall.com
Thanks a lot....
Dav, whats your opinion on CREE:
Bought Cree @ 22.50$, is it good to hold...
Shorted @ $45.86 and coverd at $42.68
1000 shares.....
Shorted TSPT @$7.43
Ron, Thanks.
But still if thats the case why no single institution invested in this for the last 8 Months.
also insiders sold all of their shares.
Reference to Lupus, we have seen Benlysta from HGSI/ Glaxo.
HGSI's highs reached upto 35$, and teh current price is $7...
Qcor Lupus i guess will take atleast 3 to 4 yrs from now.
Also the Europe is a major player, in terms of trading going forward for the next few months.
QCOR already spiked 300%.......
Ron, What is your opinion/View on Qcor.
I shorted it @45.86....
Do you really think it goes above $50, with the current market conditions.
I always see analysts give unrealistic price targets.
Also insiders sold majority of their holdings.
Since Apr 2011 haven't seen any institutional 13 D filings.
kind regards..
MONTREUX EQUITY PARTNERS sold majority tspt holdings....
MONTREUX EQUITY PARTNERS II filed form 13 D:
http://secfilings.nasdaq.com/filingFrameset.asp?FileName=0001104659%2D11%2D068416%2Etxt&FilePath=%5C2011%5C12%5C08%5C&CoName=TRANSCEPT+PHARMACEUTICALS+INC&FormType=SC+13D%2FA&RcvdDate=12%2F8%2F2011&pdf=
Show us how many shares does CFO, Sr. VP and VP(general cousel) still holding.
My message was only reference to those three.
Not the rest...... those three sold the majority of their TSPT shares.
You shouod look at all the Post FDA approvals from 2010 onwards, tell me which approval stocks did best.....
CFO, Sr. VP, VP all sold their major TSPT holdings
He sold last week 50k shares @ $8 range....
you can check sec form 4 filings....
Bunch of other insiders sold last week after purdue deal announcement.
Until options expiration share price might go low to $5 range, and then may be @ that point shorts may cover.
It all depends, this is not a super drug.
It is low dose ambien.
If the drug is a blockbuster we would have seen few institutional buying.
All fda approved drugs go down quiet a bit until they start showing some revenues....
It is a waiting game.
Shorts already on attack mode......
Good luck guys......